Bacterial Disease Diagnostics Market Trends

  • Report ID: 5206
  • Published Date: Sep 01, 2023
  • Report Format: PDF, PPT

Bacterial Disease Diagnostics Market Trends

Growth Drivers

  • Rising Government Initiatives for Better Healthcare– In 2021, the World Health Organization started the initiative Global Health and Peaces to address the critical health needs of people and to address 70% of disease outbreaks under this program. Bacterial illness diagnostics are critical for early diagnosis and prompt management of infections, which coincides with the government's preventative healthcare aims.
  • Increasing Emissions from Vehicles– Motor vehicles emit around 1.5 billion tonnes of greenhouse gases (GHGs) directly into the atmosphere each year. Poor air quality is linked to respiratory problems as well as compromised immune systems, rendering people more susceptible to bacterial illnesses. Therefore, the growing vehicular emissions will increase the need for bacterial disease diagnostics to treat infections.
  • Growing Need for Wastewater Treatment- Around 50% of wastewater generated in the world is carefully treated. To test the effectiveness of water and wastewater treatment, the need for bacterial diagnosis becomes highly important. Screening indicator bacteria levels in wastewater aids in making sure that the outcome of residential and industrial wastewater treatment is safe for discharge into the environment.

Challenges

  • Lack of Skilled Personnel and Adequate Infrastructure- Many developing countries do not have well-established infrastructure for advanced diagnostic technologies. Moreover, there is a lack of funds and skilled people to carry on the procedure effectively.
  • Low Awareness Regarding the Diagnosis of Bacterial Diseases
  • High Cost of Manufacturing

Bacterial Disease Diagnostics Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~8%

Base Year Market Size (2022)

~ USD 3 Billion

Forecast Year Market Size (2035)

~ USD 8 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5206
  • Published Date: Sep 01, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of bacterial infection and technological advancement in diagnostic technology are the major factors driving the market growth.

The market size of bacterial disease diagnostics is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 – 2035.

The major players in the market are bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, and GENERI BIOTECH s.r.o.

The bacterial skin infection segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying